The vanishing zero revisited: Thresholds in the age of genomics

Chemico-Biological Interactions

Volumn 184, Issue 1-2, 2010, Pages 273-278

  Zarbl, Helmut ^a   Gallo, Michael A ^a   Glick, James ^b   Yeung, Ka Yee ^c   Vouros, Paul ^b  

^a RUTGERS UNIVERSITY   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Low dose response; No observable transcriptional effect level; Risk assessment; Toxicogenomics

Indexed keywords

BENZENE; CARCINOGEN;

ARTICLE; BONE MARROW TOXICITY; CARCINOGEN DNA INTERACTION; CARCINOGENIC ACTIVITY; CYTOTOXICITY; ENVIRONMENTAL EXPOSURE; FUNCTIONAL GENOMICS; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; NONHUMAN; RISK ASSESSMENT; RISK MANAGEMENT; SIGNAL TRANSDUCTION; TARGET CELL; TOXICOGENETICS;

ANIMALS; BENZENE; BONE MARROW; ENVIRONMENTAL EXPOSURE; GENOMICS; HUMANS; RISK ASSESSMENT; TOXICOGENETICS; XENOBIOTICS;

EID: 77950611240     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.01.031     Document Type: Article

References (50)

1. The Vanishing Zero: The Evolution of Pesticide Analysis 1970, Academic Press, Inc., New York, London. G. Zweig (Ed.).
2. Ricicki E.M., Luo W., Fan W., Zhao L.P., Zarbl H., Vouros P. Quantification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human lymphoblastoid TK6 cells dosed with N-hydroxy-4-acetylaminobiphenyl and their relationship to mutation, toxicity, and gene expression profiling. Analytical Chemistry 2006, 78(18):6422-6432.
3. Dingley K.H., Roberts M.L., Velsko C.A., Turteltaub K.W. Attomole detection of 3H in biological samples using accelerator mass spectrometry: application in low-dose, dual-isotope tracer studies in conjunction with 14C accelerator mass spectrometry. Chem. Res. Toxicol. 1998, 11(10):1217-1222.
4. Turteltaub K.W, Dingley K.H. Application of accelerated mass spectrometry (AMS) in DNA adduct quantification and identification. Toxicol. Lett. 1998, 102-103:435-439.
5. Randall K.L., Argoti D., Paonessa J.D., Ding Y., Oaks Z., Zhang Y., Vouros P. An improved liquid chromatography-tandem mass spectrometry method for the quantification of 4-aminobiphenyl DNA adducts in urinary bladder cells and tissues. J. Chromatogr. A 2009.
6. Saltelli A., Funtowicz S. The precautionary principle: implications for risk management strategies. Int. J. Occup. Med. Environ. Health 2004, 17(1):47-57.
7. Goldstein B.D., Carruth R.S. Implications of the precautionary principle: is it a threat to science?. Int. J. Occup. Med. Environ. Health 2004, 17(1):153-161.
8. Science and Decisions 2009, National Research Council, Washington, DC.
9. Omenn G.S. Assessing the risk assessment paradigm. Toxicology 1995, 102(1-2):23-28.
10. Lee K.M., Han S., Park W.Y., Kang D. Identification and application of biomarkers in molecular and genomic epidemiologic research. J. Prev. Med. Public Health 2009, 42(6):349-355.
11. La D.K., Swenberg J.A. DNA adducts: biological markers of exposure and potential applications to risk assessment. Mutat. Res. 1996, 365(1-3):129-146.
12. Swenberg J.A., Fryar-Tita E., Jeong Y.C., Boysen G., Starr T., Walker V.E., Albertini R.J. Biomarkers in toxicology and risk assessment: informing critical dose-response relationships. Chem. Res. Toxicol. 2008, 21(1):253-265.
13. Swenberg J.A., Ham A., Koc H., Morinello E., Ranasinghe A., Tretyakova N., Upton P.B., Wu K. DNA adducts: effects of low exposure to ethylene oxide, vinyl chloride and butadiene. Mutat. Res. 2000, 464(1):77-86.
14. Marsden D.A, Jones D.J., Britton R.G., Ognibene T., Ubick E., Johnson G.E., Farmer P.B., Brown K. Dose-response relationships for N7-(2-hydroxyethyl)guanine induced by low-dose [14C]ethylene oxide: evidence for a novel mechanism of endogenous adduct formation. Cancer Res. 2009, 69(7):3052-3059.
15. Preston R.J., Fennell T.R., Leber A.P., Sielken R.L., Swenberg J.A. Reconsideration of the genetic risk assessment for ethylene oxide exposures. Environ. Mol. Mutagen. 1995, 26(3):189-202.
16. Doak S.H., Jenkins G.J., Johnson G.E., Quick E., Parry E.M., Parry J.M. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res. 2007, 67(8):3904-3911.
17. Bailey G.S., Reddy A.P., Pereira C.B., Harttig U., Baird W., Spitsbergen J.M., Hendricks J.D., Orner G.A., Williams D.E., Swenberg J.A. Nonlinear cancer response at ultralow dose: a 40800-animal ED(001) tumor and biomarker study. Chem. Res. Toxicol. 2009, 22(7):1264-1276.
18. Jenkins G.J., Doak S.H., Johnson G.E., Quick E., Waters E.M., Parry J.M. Do dose-response thresholds exist for genotoxic alkylating agents?. Mutagenesis 2005, 20(6):389-398.
19. Johnson G.E., Doak S.H., Griffiths S.M., Quick E.L., Skibinski D.O., Zair Z.M., Jenkins G.J. Non-linear dose-response of DNA-reactive genotoxins: recommendations for data analysis. Mutat. Res. 2009.
20. Gocke E., Muller L. In vivo studies in the mouse to define a threshold for the genotoxicity of EMS and ENU. Mutat. Res. 2009, 678(2):101-107.
21. Muller L., Gocke E., Lave T., Pfister T. Ethyl methanesulfonate toxicity in Viracept-a comprehensive human risk assessment based on threshold data for genotoxicity. Toxicol. Lett. 2009, 190(3):317-329.
22. Pottenger L.H., Carmichael N., Banton M.I., Boogaard P.J., Kim J., Kirkland D., Phillips R.D., van Benthem J., Williams G.M., Castrovinci A. ECETOC workshop on the biological significance of DNA adducts: summary of follow-up from an expert panel meeting. Mutat. Res. 2009, 678(2):152-157.
23. Bushel P.R., Heinloth A.N., Li J., Huang L., Chou J.W., Boorman G.A., Malarkey D.E., Houle C.D., Ward S.M., Wilson R.E., Fannin R.D., Russo M.W., Watkins P.B., Tennant R.W., Paules R.S. Blood gene expression signatures predict exposure levels. Proc. Natl. Acad. Sci. U.S.A. 2007, 104(46):18211-18216.
24. Thomas R.S., Bao W., Chu T.M., Bessarabova M., Nikolskaya T., Nikolsky Y., Andersen M.E., Wolfinger R.D. Use of short-term transcriptional profiles to assess the long-term cancer-related safety of environmental and industrial chemicals. Toxicol. Sci. 2009, 112(2):311-321.
25. Toxicity Testing in the 21st Century. A Vision and a Strategy 2007, National Research Council, Washington, DC.
26. Collins F.S., Gray G.M., Bucher J.R. Toxicology. Transforming environmental health protection. Science 2008, 319(5865):906-907.
27. Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment 2007, National Research Council, Washington, DC.
28. Lobenhofer E.K., Cui X., Bennett L., Cable P.L., Merrick B.A., Churchill G.A., Afshari C.A. Exploration of low-dose estrogen effects: identification of no observed transcriptional effect level (NOTEL). Toxicol. Pathol. 2004, 32(4):482-492.
29. Naciff J.M., Hess K.A., Overmann G.J., Torontali S.M., Carr G.J., Tiesman J.P., Foertsch L.M., Richardson B.D., Martinez J.E., Daston G.P. Gene expression changes induced in the testis by transplacental exposure to high and low doses of 17{alpha}-ethynyl estradiol, genistein, or bisphenol A. Toxicol. Sci. 2005, 86(2):396-416.
30. Poynton H.C., Loguinov A.V., Varshavsky J.R., Chan S., Perkins E.J., Vulpe C.D. Gene expression profiling in Daphnia magna. Part I. Concentration-dependent profiles provide support for the no observed transcriptional effect level. Environ. Sci. Technol. 2008, 42(16):6250-6256.
31. Benjamini Y., Heller R. Screening for partial conjunction hypotheses. Biometrics 2008, 64(4):1215-1222.
32. Gottardo R., Raftery A.E., Yeung K.Y., Bumgarner R.E. Bayesian robust inference for differential gene expression in microarrays with multiple samples. Biometrics 2006, 62(1):10-18.
33. Thomas R.S., Allen B.C., Nong A., Yang L., Bermudez E., Clewell H.J., Andersen M.E. A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. Toxicol. Sci. 2007, 98(1):240-248.
34. Yang L., Allen B.C., Thomas R.S. BMDExpress: a software tool for the benchmark dose analyses of genomic data. BMC Genomics 2007, 8:387.
35. Pottenger L.H., Gollapudi B.B. A case for a new paradigm in genetic toxicology testing. Mutat. Res. 2009.
36. Hendriksen P.J., Freidig A.P., Jonker D., Thissen U., Bogaards J.J., Mumtaz M.M., Groten J.P., Stierum R.H. Transcriptomics analysis of interactive effects of benzene, trichloroethylene and methyl mercury within binary and ternary mixtures on the liver and kidney following subchronic exposure in the rat. Toxicol. Appl. Pharmacol. 2007, 225(2):171-188.
37. Friedberg E.C., Wagner R., Radman M. Specialized DNA polymerases, cellular survival, and the genesis of mutations. Science 2002, 296(5573):1627-1630.
38. Lv L., Kerzic P., Lin G., Schnatter A.R., Bao L., Yang Y., Zou H., Fu H., Ye X., Gross S.A., Armstrong T.W., Irons R.D. The TNF-alpha 238A polymorphism is associated with susceptibility to persistent bone marrow dysplasia following chronic exposure to benzene. Leuk. Res. 2007, 31(11):1479-1485.
39. Hirabayashi Y., Yoon B.I., Li G.X., Kanno J., Inoue T. Mechanism of benzene-induced hematotoxicity and leukemogenicity: current review with implication of microarray analyses. Toxicol. Pathol. 2004, 32(Suppl. 2):12-16.
40. Snyder R., Witz G., Goldstein B.D. The toxicology of benzene. Environ. Health Perspect. 1993, 100:293-306.
41. Yoon B.I., Li G.X., Kitada K., Kawasaki Y., Igarashi K., Kodama Y., Inoue T., Kobayashi K., Kanno J., Kim D.Y., Hirabayashi Y. Mechanisms of benzene-induced hematotoxicity and leukemogenicity: cDNA microarray analyses using mouse bone marrow tissue. Environ. Health Perspect. 2003, 111(11):1411-1420.
42. Snyder R., Hedli C.C. An overview of benzene metabolism. Environ. Health Perspect. 1996, 104(Suppl. 6):1165-1171.
43. Laskin J.D., Rao N.R., Punjabi C.J., Laskin D.L., Synder R. Distinct actions of benzene and its metabolites on nitric oxide production by bone marrow leukocytes. J. Leukoc. Biol. 1995, 57(3):422-426.
44. Bird M.G., Greim H., Snyder R., Rice J.M. International symposium: recent advances in benzene toxicity. Chem. Biol. Interact. 2005, 153-154:1-5.
45. Irons R.D., Lv L., Gross S.A., Ye X., Bao L., Wang X.Q., Ryder J., Armstrong T.W., Zhou Y., Miao L., Le A.T., Kerzic P.J., Ni W., Fu H. Chronic exposure to benzene results in a unique form of dysplasia. Leuk. Res. 2005, 29(12):1371-1380.
46. Liu H., Liang Y., Bowes S., Xu H., Zhou Y., Armstrong T.W., Wong O., Schnatter A.R., Fang J., Wang L., Nie L., Fu H., Irons R. Benzene exposure in industries using or manufacturing paint in China-a literature review, 1956-2005. J. Occup. Environ. Hyg. 2009, 6(11):659-670.
47. Synder C.A., Goldstein B.D., Sellakumar A., Wolman S.R., Bromberg I., Erlichman M.N., Laskin S. Hematotoxicity of inhaled benzene to Sprague-Dawley rats and AKR mice at 300ppm. J. Toxicol. Environ. Health 1978, 4(4):605-618.
48. Faiola B., Fuller E.S., Wong V.A., Recio L. Gene expression profile in bone marrow and hematopoietic stem cells in mice exposed to inhaled benzene. Mutat. Res. 2004, 549(1-2):195-212.
49. Smith M.T., Vermeulen R., Li G., Zhang L., Lan Q., Hubbard A.E., Forrest M.S., McHale C., Zhao X., Gunn L., Shen M., Rappaport S.M., Yin S., Chanock S., Rothman N. Use of 'Omic' technologies to study humans exposed to benzene. Chem. Biol. Interact. 2005, 153-154:123-127.
50. Forrest M.S., Lan Q., Hubbard A.E., Zhang L., Vermeulen R., Zhao X., Li G., Wu Y.Y., Shen M., Yin S., Chanock S.J., Rothman N., Smith M.T. Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers. Environ. Health Perspect. 2005, 113(6):801-807.